Literature DB >> 24881764

How to train your dragon: targeted delivery of microRNA to cancer cells in vivo.

Marcin Kortylewski1, Sergey Nechaev2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24881764      PMCID： PMC4048907          DOI： 10.1038/mt.2014.73

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Kevin Struhl
Journal:  Cell       Date:  2009-10-29       Impact factor: 41.582

Review 2.  Developing microRNA therapeutics: approaching the unique complexities.

Authors:  Aimee L Jackson; Arthur A Levin
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

3.  Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

Authors:  Carla L Esposito; Laura Cerchia; Silvia Catuogno; Gennaro De Vita; Justin P Dassie; Gianluca Santamaria; Piotr Swiderski; Gerolama Condorelli; Paloma H Giangrande; Vittorio de Franciscis
Journal:  Mol Ther       Date:  2014-01-20       Impact factor: 11.454

4.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.

Authors:  Muller Fabbri; Ramiro Garzon; Amelia Cimmino; Zhongfa Liu; Nicola Zanesi; Elisa Callegari; Shujun Liu; Hansjuerg Alder; Stefan Costinean; Cecilia Fernandez-Cymering; Stefano Volinia; Gulnur Guler; Carl D Morrison; Kenneth K Chan; Guido Marcucci; George A Calin; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-21       Impact factor: 11.205

5.  Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape.

Authors:  Sergey Nechaev; Chan Gao; Dayson Moreira; Piotr Swiderski; Agnieszka Jozwiak; Claudia M Kowolik; Jiehua Zhou; Brian Armstrong; Andrew Raubitschek; John J Rossi; Marcin Kortylewski
Journal:  J Control Release       Date:  2013-06-15       Impact factor: 9.776

6.  Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.

Authors:  James O McNamara; Despina Kolonias; Fernando Pastor; Robert S Mittler; Lieping Chen; Paloma H Giangrande; Bruce Sullenger; Eli Gilboa
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

7.  Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors:  Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

Review 8.  The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.

Authors:  Juliano D Paccez; Matjaz Vogelsang; M Iqbal Parker; Luiz F Zerbini
Journal:  Int J Cancer       Date:  2013-06-04       Impact factor: 7.396

9.  Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

Authors:  Janaiah Kota; Raghu R Chivukula; Kathryn A O'Donnell; Erik A Wentzel; Chrystal L Montgomery; Hun-Way Hwang; Tsung-Cheng Chang; Perumal Vivekanandan; Michael Torbenson; K Reed Clark; Jerry R Mendell; Joshua T Mendell
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  Targeting Axl with an high-affinity inhibitory aptamer.

Authors:  Laura Cerchia; Carla L Esposito; Simona Camorani; Anna Rienzo; Loredana Stasio; Luigi Insabato; Andrea Affuso; Vittorio de Franciscis
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454
View more
  8 in total

1.  Roles for noncoding RNAs in cell-fate determination and regeneration.

Authors:  Mo Li; Juan Carlos Izpisua Belmonte
Journal:  Nat Struct Mol Biol       Date:  2015-01       Impact factor: 15.369

Review 2.  HDL and microRNA therapeutics in cardiovascular disease.

Authors:  Danielle L Michell; Kasey C Vickers
Journal:  Pharmacol Ther       Date:  2016-09-03       Impact factor: 12.310

3.  Polyethyleneimine-coated quantum dots for miRNA delivery and its enhanced suppression in HepG2 cells.

Authors:  Gaofeng Liang; Yang Li; Wenpo Feng; Xinshuai Wang; Aihua Jing; Jinghua Li; Kaiwang Ma
Journal:  Int J Nanomedicine       Date:  2016-11-15

4.  Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells.

Authors:  Gaofeng Liang; Shu Kan; Yanliang Zhu; Shuying Feng; Wenpo Feng; Shegan Gao
Journal:  Int J Nanomedicine       Date:  2018-01-30

Review 5.  Role of let-7 family microRNA in breast cancer.

Authors:  Chadrashekar Kagepura Thammaiah; Shankar Jayaram
Journal:  Noncoding RNA Res       Date:  2016-11-04

6.  Bimodular Antiparallel G-Quadruplex Nanoconstruct with Antiproliferative Activity.

Authors:  Olga Antipova; Nadezhda Samoylenkova; Ekaterina Savchenko; Elena Zavyalova; Alexander Revishchin; Galina Pavlova; Alexey Kopylov
Journal:  Molecules       Date:  2019-10-08       Impact factor: 4.411

Review 7.  microRNAs as Novel Therapeutics in Cancer.

Authors:  Giulia Romano; Mario Acunzo; Patrick Nana-Sinkam
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 8.  MicroRNA Targeting to Modulate Tumor Microenvironment.

Authors:  Praneeth R Kuninty; Jonas Schnittert; Gert Storm; Jai Prakash
Journal:  Front Oncol       Date:  2016-01-19       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.